UTI

UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option

Latest NAV

₹14.7526

As of

28 Sep 2021

1,233 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	+0.01%	-0.06%	+0.07	189 / 268	Q3
1W	-0.03%	-0.01%	-0.02	255 / 267	Q4
2W	-0.25%	+0.08%	-0.34	256 / 267	Q4
1M	+0.64%	+0.31%	+0.33	24 / 267	Q1
3M	+2.82%	+1.23%	+1.59	7 / 267	Q1
6M	+5.97%	+2.66%	+3.31	9 / 240	Q1
YTD	+7.99%	+2.32%	+5.67	8 / 249	Q1
1Y	+12.91%	+5.93%	+6.98	10 / 236	Q1
2Y	+11.27%	+6.76%	+4.51	2 / 236	Q1
3Y	+10.18%	+6.97%	+3.22	2 / 236	Q1
4Y	+7.97%	+6.86%	+1.11	3 / 43	Q1
5Y	+8.06%	+6.61%	+1.45	3 / 24	Q1
7Y	—	—	—	—	—
10Y	—	—	—	—	—
Inception	+8.05%	+6.37%	+1.68	29 / 268	Q1

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2021 YTD	+7.99%	+3.46%	+4.53	8 / 120
2020	+11.66%	+7.10%	+4.56	2 / 158
2019	+8.65%	+7.06%	+1.58	79 / 146
2018	+1.01%	+5.18%	-4.18	77 / 82
2017	+8.91%	+7.89%	+1.02	10 / 36
2016	—	—	—	—

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+7.59%

49 windows

min 0.4% · max 17.7%

100% positive

Limited basis — fund is young, so this average may be skewed by which 1Y windows happen to be available.

3-Year rolling

+6.98%

25 windows

min 4.6% · max 10.2%

100% positive

Limited basis — fund is young, so this average may be skewed by which 3Y windows happen to be available.

5-Year rolling

+8.06%

1 window

min 8.1% · max 8.1%

100% positive

Limited basis — fund is young, so this average may be skewed by which 5Y windows happen to be available.

7-Year rolling

—

Insufficient history

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

3.88%

3-year · annualised

Sharpe ratio

0.85

vs risk-free 6.5%

Sortino ratio

1.52

Downside-only deviation

Max drawdown

-7.94%

Feb 2020 → Mar 2020

% positive months

83.3%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Medium to Long Duration Fund

Scheme	Fund house	NAV	As of
Nippon India Fixed Maturity Plan-XLIII-Series 5- Regular Plan-Growth Option	Nippon India	₹13.3689	17 Jul 2026
SBI Fixed Maturity Plan (FMP) - Series 1 (3668 Days) - Regular Plan - Growth	SBI	₹17.4778	17 Jul 2026
BANDHAN Fixed Term Plan Series 179 REGULAR PLAN-GROWTH (3652 days)	Bandhan	₹17.7557	17 Jul 2026
Aditya Birla Sun Life Fixed Term Plan - Series TJ (1838 days) - Regular Plan - Growth Option	Aditya Birla Sun Life	₹13.5537	17 Jul 2026
Kotak FMP Series 304-Regular Plan-Growth Option	Kotak	₹13.2821	17 Jul 2026
DSP FMP Series - 264 - 60M - 17D - Regular Plan - Growth	DSP	₹13.2422	17 Jul 2026
UTI Fixed Term Income Fund Series XXXVI - I (1574 Days) - Regular Plan - Growth Option	UTI	₹12.7817	17 Jul 2026
Axis Fixed Term Plan - Series 113 (1228 Days) - Regular Plan - Growth	Axis	₹12.5758	17 Jul 2026
TRUSTMF FIXED MATURITY PLAN -SERIES II (1196 DAYS)-REGULAR PLAN -GROWTH		₹1,294.2584	9 Jul 2026

Recent NAVs

Date	NAV
28 Sep 2021	₹14.7526
27 Sep 2021	₹14.7517
24 Sep 2021	₹14.7490
23 Sep 2021	₹14.7481
22 Sep 2021	₹14.7473
21 Sep 2021	₹14.7563
20 Sep 2021	₹14.7491
17 Sep 2021	₹14.7945
16 Sep 2021	₹14.8139
15 Sep 2021	₹14.8161

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 28 Sep 2021, the NAV of UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option is ₹14.7526. It's a Medium to Long Duration Fund from UTI, run as a Regular plan Growth option. NAVs update once per business day from the AMFI feed.

UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option has NAV history starting from 28 Sep 2016, a track record of about 9 years 9 months. That's enough history to evaluate the fund across one or two market cycles. Look at rolling returns rather than point-to-point to judge consistency.

UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option is managed by UTI. It's classified by AMFI under the 'Medium to Long Duration Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option has delivered a absolute return of 12.91% — +6.98 pp ahead of the Medium to Long Duration Fund category average of 5.93%. The fund ranks #10 of 236 in its category — the top (Q1) quartile.

Over the trailing 3-year window, UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option has delivered a CAGR of 10.18% — +3.22 pp ahead of the Medium to Long Duration Fund category average of 6.97%. The fund ranks #2 of 236 in its category — the top (Q1) quartile.

Over the trailing 5-year window, UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option has delivered a CAGR of 8.06% — +1.45 pp ahead of the Medium to Long Duration Fund category average of 6.61%. The fund ranks #3 of 24 in its category — the top (Q1) quartile.

₹1 lakh invested in UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option exactly 5 years ago would be worth approximately ₹147,361 today — a multiplier of 1.47×, based on the 5-year CAGR of 8.06%. The category average over the same window would have grown ₹1 lakh to ₹137,711.

A ₹10,000 monthly SIP in UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option over the last 5 years — total invested ₹600,000 — would be worth ₹757,060 today. That's an XIRR (money-weighted annualised return) of 9.22%.

UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option doesn't yet have 10 years of NAVs. Over the longest available window (5-year SIP), ₹10,000/month would have grown to ₹757,060 — XIRR 9.22%.

On a 5-year basis, UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option ranks #3 out of 24 funds in the Medium to Long Duration Fund category — that places it in the top quartile (Q1) — strong outperformance. The category average return over the same window is 6.61%; this fund delivered 8.06%.

The worst peak-to-trough decline UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option has experienced over the last 5-year window is 7.94% — its NAV fell from a high on 19 Feb 2020 to a low on 23 Mar 2020. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 5-year rolling windows, UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option averaged 8.06% (best 8.06%, worst 8.06%). 100% of rolling windows ended positive. The 5-year Sharpe ratio is 0.35 — weak risk-adjusted performance.

In calendar year 2020, UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option returned 11.66% — beating the Medium to Long Duration Fund category average of 7.10% by 4.56 pp. It ranked #2 of 158 in its category that year.

UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option is classified as a Debt fund. For units acquired on or after 1 April 2023, all gains are taxed at your income-tax slab rate regardless of holding period — there's no LTCG concession or indexation. For pre-April-2023 units, the old rules with indexation still apply on long-term gains.

We don't give personal investment advice. UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option is suitable for an investor whose:

time horizon matches the fund's modified duration — short-duration funds for 1-3 year goals, long-duration for 7+ years
primary goal is capital preservation or steady accrual, not high growth
tax slab is moderate — high-slab investors should evaluate post-tax yield against tax-free alternatives (PPF, tax-free bonds)

Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 7.9%. 5-year CAGR: 8.06%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.

UTI Capital Protection Oriented Scheme Series VIII - II (1831 Days) - Regular Plan - Growth Option

NAV history & peer comparison

Returns matrix

Calendar-year returns

Rolling returns

SIP returns — historical "what if"

Risk profile

Peers in Medium to Long Duration Fund

Recent NAVs

Frequently asked questions

More from UTI